Résumé des résultats de recherche
De Santé Canada
Critères de recherche
- État : Aucune restriction
- Numéro de groupe d'ingrédients actifs (GIA) : 0113778001
Résultats de la recherche
| État | DIN | Entreprise | Nom du produit | Classe | MP Voir la note1 | Annexe | # Voir la note2 | Nom d'un I.A. Voir la note3 | Concentration |
|---|---|---|---|---|---|---|---|---|---|
| Approuvé | 02538644 | FRESENIUS KABI CANADA LTD | 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION | Humain | Oui | Spécialité médicale | 1 | Gluconate de calcium | 20 MG / ML |
| Commercialisé | 02403536 | FRESENIUS KABI CANADA LTD | 5% DEXTROSE INJECTION | Humain | Oui | Spécialité médicale | 1 | Dextrose (Dextrose) | 50 MG / ML |
| Commercialisé | 02434458 | FRESENIUS KABI CANADA LTD | ACIDE ZOLÉDRONIQUE POUR INJECTION | Humain | Oui | Prescription | 1 | Acide zolédronique (Acide zolédronique monohydraté) | 4 MG / 5 ML |
| Commercialisé | 02236926 | FRESENIUS KABI CANADA LTD | ACYCLOVIR SODIUM INJECTION | Humain | Oui | Prescription | 1 | Acyclovir (Acyclovir sodique) | 50 MG / ML |
| Commercialisé | 02497697 | FRESENIUS KABI CANADA LTD | ADDNUTRIV | Humain | Oui | Spécialité médicale | 9 | Chrome (Chlorure de chrome) | 10 MCG / 10 ML |
| Commercialisé | 02267659 | FRESENIUS KABI CANADA LTD | ADÉNOSINE INJECTABLE | Humain | Oui | Prescription | 1 | Adénosine | 3 MG / ML |
| Commercialisé | 02457474 | FRESENIUS KABI CANADA LTD | ADÉNOSINE INJECTABLE | Humain | Oui | Prescription | 1 | Adénosine | 3 MG / ML |
| Commercialisé | 02457482 | FRESENIUS KABI CANADA LTD | ADÉNOSINE INJECTABLE | Humain | Oui | Prescription | 1 | Adénosine | 3 MG / ML |
| Commercialisé | 02245248 | FRESENIUS KABI CANADA LTD | AMIODARONE HYDROCHLORIDE FOR INJECTION, USP | Humain | Non | Prescription | 1 | Chlorhydrate d'amiodarone | 50 MG / ML |
| Annulé avant commercialisation | 02227037 | FRESENIUS KABI CANADA LTD | AMPICILLIN FOR INJECTION | Humain | Non | Prescription | 1 | Ampicilline (Ampicilline sodique) | 125 MG / Fiole |
| Commercialisé | 02226995 | FRESENIUS KABI CANADA LTD | AMPICILLIN FOR INJECTION, USP | Humain | Non | Prescription | 1 | Ampicilline (Ampicilline sodique) | 2 G / Fiole |
| Commercialisé | 02227002 | FRESENIUS KABI CANADA LTD | AMPICILLIN FOR INJECTION, USP | Humain | Non | Prescription | 1 | Ampicilline (Ampicilline sodique) | 1 G / Fiole |
| Commercialisé | 02227010 | FRESENIUS KABI CANADA LTD | AMPICILLIN FOR INJECTION, USP | Humain | Non | Prescription | 1 | Ampicilline (Ampicilline sodique) | 500 MG / Fiole |
| Commercialisé | 02227029 | FRESENIUS KABI CANADA LTD | AMPICILLIN FOR INJECTION, USP | Humain | Non | Prescription | 1 | Ampicilline (Ampicilline sodique) | 250 MG / Fiole |
| Commercialisé | 02529637 | FRESENIUS KABI CANADA LTD | ANTICOAGULANT SODIUM CITRATE SOLUTION, USP | Humain | Non | Spécialité médicale | 1 | Citrate de sodium | 4 G / 100 ML |
| Commercialisé | 02505177 | FRESENIUS KABI CANADA LTD | AZACITIDINE FOR INJECTION | Humain | Oui | Prescription | 1 | Azacitidine | 100 MG / Fiole |
| Annulé avant commercialisation | 02255820 | FRESENIUS KABI CANADA LTD | BACITRACIN FOR INJECTION | Humain | Oui | Spécialité médicale | 1 | Bacitracine | 50000 Unité / Fiole |
| Annulé avant commercialisation | 02360098 | FRESENIUS KABI CANADA LTD | BICALUTAMIDE TABLETS | Humain | Oui | Prescription | 1 | Bicalutamide | 50 MG |
| Commercialisé | 02435268 | FRESENIUS KABI CANADA LTD | BIVALIRUDINE POUR INJECTION | Humain | Oui | Prescription | 1 | Bivalirudine | 250 MG / Fiole |
| Commercialisé | 02265982 | FRESENIUS KABI CANADA LTD | BLÉOMYCINE POUR INJECTION | Humain | Oui | Prescription | 1 | Bléomycine (Sulfate de bléomycine) | 15 Unité / Fiole |
| Annulé après commercialisation | 02245686 | FRESENIUS KABI CANADA LTD | CALCITRIOL INJECTION | Humain | Oui | Prescription | 1 | Calcitriol | 1 MCG / ML |
| Commercialisé | 02141019 | FRESENIUS KABI CANADA LTD | CALCIUM GLUCONATE INJECTION, USP 10% | Humain | Oui | Spécialité médicale | 1 | Gluconate de calcium | 100 MG / ML |
| Commercialisé | 02486989 | FRESENIUS KABI CANADA LTD | CASPOFUNGIN FOR INJECTION | Humain | Oui | Prescription | 1 | Caspofungine (Acétate de caspofungine) | 50 MG / Fiole |
| Commercialisé | 02486997 | FRESENIUS KABI CANADA LTD | CASPOFUNGIN FOR INJECTION | Humain | Oui | Prescription | 1 | Caspofungine (Acétate de caspofungine) | 70 MG / Fiole |
| Dormant | 02237137 | FRESENIUS KABI CANADA LTD | CEFAZOLIN FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Céfazoline (Céfazoline sodique) | 500 MG / Fiole |
| Commercialisé | 02237138 | FRESENIUS KABI CANADA LTD | CEFAZOLIN FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Céfazoline (Céfazoline sodique) | 1 G / Fiole |
| Annulé après commercialisation | 02237141 | FRESENIUS KABI CANADA LTD | CEFAZOLIN FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Céfazoline (Céfazoline sodique) | 20 G / Fiole |
| Commercialisé | 02401029 | FRESENIUS KABI CANADA LTD | CEFAZOLIN FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Céfazoline (Céfazoline sodique) | 100 G / Sac |
| Annulé après commercialisation | 02452162 | FRESENIUS KABI CANADA LTD | CÉFAZOLINE POUR INJECTION | Humain | Oui | Prescription | 1 | Céfazoline (Céfazoline sodique) | 10 G / Fiole |
| Commercialisé | 02237140 | FRESENIUS KABI CANADA LTD | CÉFAZOLINE POUR INJECTION, USP | Humain | Oui | Prescription | 1 | Céfazoline (Céfazoline sodique) | 10 G / Fiole |
| Commercialisé | 00886955 | FRESENIUS KABI CANADA LTD | CEFTAZIDIME FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Ceftazidime | 2 G / Fiole |
| Commercialisé | 00886963 | FRESENIUS KABI CANADA LTD | CEFTAZIDIME FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Ceftazidime | 6 G / Fiole |
| Commercialisé | 00886971 | FRESENIUS KABI CANADA LTD | CEFTAZIDIME FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Ceftazidime | 1 G / Fiole |
| Annulé avant commercialisation | 02289679 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE FOR INJECTION | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 250 MG / Fiole |
| Approuvé | 02289687 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE FOR INJECTION | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 500 MG / Fiole |
| Commercialisé | 02289695 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE FOR INJECTION | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 1 G / Fiole |
| Commercialisé | 02289709 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE FOR INJECTION | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 2 G / Fiole |
| Approuvé | 02289717 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE FOR INJECTION | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 10 G / Fiole |
| Commercialisé | 02409968 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE POUR INJECTION | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 100 G / Sac |
| Annulé avant commercialisation | 02465892 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE SODIQUE POUR INJECTION BP | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 250 MG / Fiole |
| Annulé avant commercialisation | 02465906 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE SODIQUE POUR INJECTION BP | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 1 G / Fiole |
| Annulé avant commercialisation | 02465914 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE SODIQUE POUR INJECTION BP | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 2 G / Fiole |
| Annulé avant commercialisation | 02465922 | FRESENIUS KABI CANADA LTD | CEFTRIAXONE SODIQUE POUR INJECTION BP | Humain | Oui | Prescription | 1 | Ceftriaxone (Ceftriaxone sodique) | 10 G / Fiole |
| Commercialisé | 02241638 | FRESENIUS KABI CANADA LTD | CEFUROXIME FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Céfuroxime (Céfuroxime sodique) | 750 MG / Fiole |
| Commercialisé | 02241639 | FRESENIUS KABI CANADA LTD | CEFUROXIME FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Céfuroxime (Céfuroxime sodique) | 1.5 G / Fiole |
| Annulé après commercialisation | 02241640 | FRESENIUS KABI CANADA LTD | CÉFUROXIME POUR INJECTION, USP | Humain | Oui | Prescription | 1 | Céfuroxime (Céfuroxime sodique) | 7.5 G / Fiole |
| Commercialisé | 02369567 | FRESENIUS KABI CANADA LTD | CHLORHYDRATE DE DIPHÉNHYDRAMINE INJECTABLE, USP | Humain | Oui | Spécialité médicale | 1 | Chlorhydrate de diphénhydramine | 50 MG / ML |
| Annulé après commercialisation | 02377470 | FRESENIUS KABI CANADA LTD | CHLORHYDRATE DE VANCOMYCINE ENCAPSULÉ, USP | Humain | Oui | Prescription | 1 | Vancomycine (Chlorhydrate de vancomycine) | 125 MG |
| Annulé après commercialisation | 02377489 | FRESENIUS KABI CANADA LTD | CHLORHYDRATE DE VANCOMYCINE ENCAPSULÉ, USP | Humain | Oui | Prescription | 1 | Vancomycine (Chlorhydrate de vancomycine) | 250 MG |
| Commercialisé | 02395150 | FRESENIUS KABI CANADA LTD | CHLORURE DE SODIUM À 0,9 % POUR PERFUSION | Humain | Oui | Spécialité médicale | 1 | Chlorure de sodium | 900 MG / 100 ML |
| Commercialisé | 02139510 | FRESENIUS KABI CANADA LTD | CHLORURE DE SODIUM INJECTABLE, USP | Humain | Oui | Spécialité médicale | 1 | Chlorure de sodium | 234 MG / ML |
| Commercialisé | 02247459 | FRESENIUS KABI CANADA LTD | CHORIONIC GONADOTROPIN FOR INJECTION, USP | Humain | Oui | Prescription | 1 | Ganodotrophine chorionique | 10000 Unité / Fiole |
| Commercialisé | 02247459 | FRESENIUS KABI CANADA LTD | CHORIONIC GONADOTROPIN FOR INJECTION, USP | Humain | Oui | Annexe D | 1 | Ganodotrophine chorionique | 10000 Unité / Fiole |
| Annulé avant commercialisation | 02274140 | FRESENIUS KABI CANADA LTD | CIPROFLOXACIN INJECTION | Humain | Oui | Prescription | 1 | Ciprofloxacine (Lactate de ciprofloxacine) | 10 MG / ML |
| Annulé avant commercialisation | 02312123 | FRESENIUS KABI CANADA LTD | CIPROFLOXACIN INJECTION | Humain | Oui | Prescription | 1 | Ciprofloxacine | 2 MG / ML |
| Approuvé | 02423782 | FRESENIUS KABI CANADA LTD | CISATRACURIUM BESYLATE INJECTION MULTI-DOSE | Humain | Oui | Prescription | 1 | Cisatracurium (Bésilate de cisatracurium) | 2 MG / ML |
| Approuvé | 02423774 | FRESENIUS KABI CANADA LTD | CISATRACURIUM BESYLATE INJECTION SINGLE DOSE | Humain | Oui | Prescription | 1 | Cisatracurium (Bésilate de cisatracurium) | 2 MG / ML |
| Approuvé | 02409186 | FRESENIUS KABI CANADA LTD | CISPLATIN INJECTION | Humain | Oui | Prescription | 1 | Cisplatine | 1 MG / ML |
| Commercialisé | 02319918 | FRESENIUS KABI CANADA LTD | CLADRIBINE INJECTION | Humain | Oui | Prescription | 1 | Cladribine | 1 MG / ML |
| Annulé après commercialisation | 02139286 | FRESENIUS KABI CANADA LTD | CLINDAMYCINE INJECTABLE, USP | Humain | Oui | Prescription | 1 | Clindamycine (Phosphate de clindamycine) | 150 MG / ML |
| Commercialisé | 02403544 | FRESENIUS KABI CANADA LTD | COLISTIMÉTHATE POUR INJECTION, USP | Humain | Oui | Prescription | 1 | Colistine (Colistiméthate sodique) | 150 MG / Fiole |
| Approuvé | 02536463 | FRESENIUS KABI CANADA LTD | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Humain | Oui | Prescription | 1 | Dexmédétomidine (Chlorhydrate de dexmédétomidine) | 4 MCG / ML |
| Commercialisé | 02244475 | FRESENIUS KABI CANADA LTD | DIPYRIDAMOLE INJECTION, USP | Humain | Oui | Prescription | 1 | Dipyridamole | 5 MG / ML |
| Commercialisé | 02532247 | FRESENIUS KABI CANADA LTD | ELONOX | Humain | Oui | Prescription | 1 | Énoxaparine sodique | 30 MG / 0.3 ML |
| Commercialisé | 02532255 | FRESENIUS KABI CANADA LTD | ELONOX | Humain | Oui | Prescription | 1 | Énoxaparine sodique | 40 MG / 0.4 ML |
| Commercialisé | 02532263 | FRESENIUS KABI CANADA LTD | ELONOX | Humain | Oui | Prescription | 1 | Énoxaparine sodique | 60 MG / 0.6 ML |
| Commercialisé | 02532271 | FRESENIUS KABI CANADA LTD | ELONOX | Humain | Oui | Prescription | 1 | Énoxaparine sodique | 80 MG / 0.8 ML |
| Commercialisé | 02532298 | FRESENIUS KABI CANADA LTD | ELONOX | Humain | Oui | Prescription | 1 | Énoxaparine sodique | 100 MG / ML |
| Commercialisé | 02532301 | FRESENIUS KABI CANADA LTD | ELONOX HP | Humain | Oui | Prescription | 1 | Énoxaparine sodique | 120 MG / 0.8 ML |
| Commercialisé | 02532328 | FRESENIUS KABI CANADA LTD | ELONOX HP | Humain | Oui | Prescription | 1 | Énoxaparine sodique | 150 MG / ML |
| Dormant | 02312093 | FRESENIUS KABI CANADA LTD | EPIRUBICIN HYDROCHLORIDE INJECTION | Human | Oui | Prescription | 1 | EPIRUBICIN HYDROCHLORIDE | 2.0 MG / ML |
| Cancelled Pre Market | 02460378 | FRESENIUS KABI CANADA LTD | EPTIFIBATIDE INJECTION | Human | Oui | Prescription | 1 | EPTIFIBATIDE | 0.75 MG / ML |
| Cancelled Pre Market | 02460386 | FRESENIUS KABI CANADA LTD | EPTIFIBATIDE INJECTION | Human | Oui | Prescription | 1 | EPTIFIBATIDE | 2 MG / ML |
| Marketed | 02496127 | FRESENIUS KABI CANADA LTD | ERTAPENEM FOR INJECTION | Human | Oui | Prescription | 1 | ERTAPENEM (ERTAPENEM SODIUM) | 1 G / VIAL |
| Marketed | 02510324 | FRESENIUS KABI CANADA LTD | ESSEPNA | Human | Oui | Ethical | 16 | ALANINE | 1.4 G / 100 ML |
| Marketed | 02537508 | FRESENIUS KABI CANADA LTD | ETOMIDATE INJECTION, USP | Human | Oui | Prescription | 1 | ETOMIDATE | 2 MG / ML |
| Dormant | 02239961 | FRESENIUS KABI CANADA LTD | ETOPOSIDE INJECTION | Human | Oui | Prescription | 1 | ETOPOSIDE | 20 MG / ML |
| Approved | 02244133 | FRESENIUS KABI CANADA LTD | FAMOTIDINE INJECTION | Human | Oui | Prescription | 1 | FAMOTIDINE | 10 MG / ML |
| Marketed | 02501554 | FRESENIUS KABI CANADA LTD | FENTANYL CITRATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | FENTANYL (FENTANYL CITRATE) | 50 MCG / ML |
| Cancelled Pre Market | 02248731 | FRESENIUS KABI CANADA LTD | FLUCONAZOLE INJECTION | Human | Oui | Prescription | 1 | FLUCONAZOLE | 2 MG / ML |
| Cancelled Pre Market | 02351730 | FRESENIUS KABI CANADA LTD | FLUDARABINE PHOSPHATE FOR INJECTION | Human | Oui | Prescription | 1 | FLUDARABINE PHOSPHATE | 50 MG / VIAL |
| Dormant | 02351722 | FRESENIUS KABI CANADA LTD | FLUDARABINE PHOSPHATE INJECTION | Human | Oui | Prescription | 1 | FLUDARABINE PHOSPHATE | 25 MG / ML |
| Marketed | 02266342 | FRESENIUS KABI CANADA LTD | FLUMAZENIL INJECTION, USP | Human | Oui | Ethical | 1 | FLUMAZENIL | 0.1 MG / ML |
| Marketed | 02139480 | FRESENIUS KABI CANADA LTD | FOLIC ACID INJECTION, USP | Human | Oui | Ethical | 1 | FOLIC ACID (SODIUM FOLATE) | 5 MG / ML |
| Marketed | 02404761 | FRESENIUS KABI CANADA LTD | GANCICLOVIR FOR INJECTION | Human | Oui | Prescription | 1 | GANCICLOVIR (GANCICLOVIR SODIUM) | 500 MG / VIAL |
| Approved | 02412071 | FRESENIUS KABI CANADA LTD | GEMCITABINE FOR INJECTION | Human | Oui | Prescription | 1 | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) | 200 MG / VIAL |
| Approved | 02412098 | FRESENIUS KABI CANADA LTD | GEMCITABINE FOR INJECTION | Human | Oui | Prescription | 1 | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) | 1 G / VIAL |
| Approved | 02412101 | FRESENIUS KABI CANADA LTD | GEMCITABINE FOR INJECTION | Human | Oui | Prescription | 1 | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) | 2 G / VIAL |
| Marketed | 02406411 | FRESENIUS KABI CANADA LTD | HALOPERIDOL INJECTION, USP | Human | Oui | Prescription | 1 | HALOPERIDOL | 5 MG / ML |
| Marketed | 02264307 | FRESENIUS KABI CANADA LTD | HEPARIN SODIUM INJECTION, USP | Human | Oui | Ethical | 1 | HEPARIN SODIUM | 10000 UNIT / ML |
| Marketed | 02264315 | FRESENIUS KABI CANADA LTD | HEPARIN SODIUM INJECTION, USP | Human | Oui | Ethical | 1 | HEPARIN SODIUM | 1000 UNIT / ML |
| Marketed | 02392453 | FRESENIUS KABI CANADA LTD | HEPARIN SODIUM INJECTION, USP | Human | Oui | Ethical | 1 | HEPARIN SODIUM | 10000 UNIT / ML |
| Approved | 02482142 | FRESENIUS KABI CANADA LTD | HEPARIN SODIUM INJECTION, USP | Human | Oui | Ethical | 1 | HEPARIN SODIUM | 10000 UNIT / ML |
| Approved | 02406012 | FRESENIUS KABI CANADA LTD | HYDRALAZINE HYDROCHLORIDE INJECTION | Human | Oui | Prescription | 1 | HYDRALAZINE HYDROCHLORIDE | 20 MG / ML |
| Marketed | 02491680 | FRESENIUS KABI CANADA LTD | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | HYDROMORPHONE HYDROCHLORIDE | 10 MG / ML |
| Marketed | 02491699 | FRESENIUS KABI CANADA LTD | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | HYDROMORPHONE HYDROCHLORIDE | 2 MG / ML |
| Cancelled Pre Market | 02242864 | FRESENIUS KABI CANADA LTD | HYDROXYZINE HYDROCHLORIDE INJECTION | Human | Non | Prescription | 1 | HYDROXYZINE HYDROCHLORIDE | 50 MG / ML |
| Approved | 02502666 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Oui | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Approved | 02502666 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Oui | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502674 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Oui | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502674 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Oui | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502682 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Oui | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502682 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Oui | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Cancelled Post Market | 02337584 | FRESENIUS KABI CANADA LTD | IDARUBICIN HYDROCHLORIDE INJECTION | Human | Oui | Prescription | 1 | IDARUBICIN HYDROCHLORIDE | 1 MG / ML |
| Cancelled Post Market | 02246565 | FRESENIUS KABI CANADA LTD | IFOSFAMIDE FOR INJECTION | Human | Oui | Prescription | 1 | IFOSFAMIDE | 1 G / VIAL |
| Cancelled Pre Market | 02246566 | FRESENIUS KABI CANADA LTD | IFOSFAMIDE FOR INJECTION | Human | Oui | Prescription | 1 | IFOSFAMIDE | 3 G / VIAL |
| Dormant | 02065681 | FRESENIUS KABI CANADA LTD | INTRALIPID 10% | Human | Oui | Ethical | 1 | SOYBEAN OIL | 10 % / W/V |
| Marketed | 02065673 | FRESENIUS KABI CANADA LTD | INTRALIPID 20% | Human | Oui | Ethical | 1 | SOYBEAN OIL | 20 % / W/V |
| Dormant | 02216175 | FRESENIUS KABI CANADA LTD | INTRALIPID 30% | Human | Oui | Ethical | 1 | SOYBEAN OIL | 30 % / W/V |
| Approved | 02553953 | FRESENIUS KABI CANADA LTD | IODIXANOL INJECTION 270 | Human | Oui | Ethical | 1 | IODIXANOL | 550 MG / ML |
| Approved | 02553961 | FRESENIUS KABI CANADA LTD | IODIXANOL INJECTION 320 | Human | Oui | Ethical | 1 | IODIXANOL | 652 MG / ML |
| Dormant | 02345080 | FRESENIUS KABI CANADA LTD | IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION | Human | Oui | Prescription | 1 | IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE) | 20 MG / ML |
| Marketed | 02231929 | FRESENIUS KABI CANADA LTD | ISOFLURANE USP | Human | Oui | Prescription | 1 | ISOFLURANE | 99.9 % |
| Marketed | 02237518 | FRESENIUS KABI CANADA LTD | ISOFLURANE USP | Veterinary | Non | Prescription | 1 | ISOFLURANE | 99.9 % |
| Approved | 02550431 | FRESENIUS KABI CANADA LTD | KETAMINE HYDROCHLORIDE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | KETAMINE (KETAMINE HYDROCHLORIDE) | 10 MG / ML |
| Approved | 02550458 | FRESENIUS KABI CANADA LTD | KETAMINE HYDROCHLORIDE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | KETAMINE (KETAMINE HYDROCHLORIDE) | 50 MG / ML |
| Approved | 02481138 | FRESENIUS KABI CANADA LTD | KETOROLAC TROMETHAMINE INJECTION, USP | Human | Oui | Prescription | 1 | KETOROLAC TROMETHAMINE | 30 MG / ML |
| Marketed | 02244947 | FRESENIUS KABI CANADA LTD | KETOROLAC TROMETHAMINE INJECTION, USP | Human | Oui | Prescription | 1 | KETOROLAC TROMETHAMINE | 30 MG / ML |
| Cancelled Pre Market | 02381958 | FRESENIUS KABI CANADA LTD | LETROZOLE TABLETS | Human | Oui | Prescription | 1 | LETROZOLE | 2.5 MG |
| Marketed | 02245948 | FRESENIUS KABI CANADA LTD | LEVOTHYROXINE SODIUM FOR INJECTION | Human | Oui | Prescription | 1 | LEVOTHYROXINE SODIUM | 500 MCG / VIAL |
| Approved | 02245947 | FRESENIUS KABI CANADA LTD | LEVOTHYROXINE SODIUM FOR INJECTION | Human | Oui | Prescription | 1 | LEVOTHYROXINE SODIUM | 200 MCG / VIAL |
| Marketed | 02499916 | FRESENIUS KABI CANADA LTD | LEVOTHYROXINE SODIUM INJECTION | Human | Oui | Prescription | 1 | LEVOTHYROXINE SODIUM | 40 MCG / ML |
| Marketed | 02499924 | FRESENIUS KABI CANADA LTD | LEVOTHYROXINE SODIUM INJECTION | Human | Oui | Prescription | 1 | LEVOTHYROXINE SODIUM | 100 MCG / ML |
| Marketed | 02430827 | FRESENIUS KABI CANADA LTD | LINEZOLID INJECTION | Human | Oui | Prescription | 1 | LINEZOLID | 2 MG / ML |
| Approved | 02550962 | FRESENIUS KABI CANADA LTD | LORAZEPAM INJECTION, USP | Human | Oui | Targeted (CDSA IV) | 1 | LORAZEPAM | 4 MG / ML |
| Marketed | 02139499 | FRESENIUS KABI CANADA LTD | MAGNESIUM SULFATE INJECTION, USP | Human | Oui | Ethical | 1 | MAGNESIUM SULFATE | 500 MG / ML |
| Marketed | 02243176 | FRESENIUS KABI CANADA LTD | MANNITOL INJECTION, USP | Human | Oui | Ethical | 1 | MANNITOL | 25 % |
| Marketed | 02415216 | FRESENIUS KABI CANADA LTD | MEROPENEM FOR INJECTION, USP | Human | Oui | Prescription | 1 | MEROPENEM | 500 MG / VIAL |
| Marketed | 02415224 | FRESENIUS KABI CANADA LTD | MEROPENEM FOR INJECTION, USP | Human | Oui | Prescription | 1 | MEROPENEM | 1 G / VIAL |
| Marketed | 02244931 | FRESENIUS KABI CANADA LTD | MESNA FOR INJECTION | Human | Oui | Prescription | 1 | MESNA | 100 MG / ML |
| Marketed | 02242904 | FRESENIUS KABI CANADA LTD | MIDAZOLAM INJECTION | Human | Oui | Targeted (CDSA IV) | 1 | MIDAZOLAM | 1 MG / ML |
| Marketed | 02242905 | FRESENIUS KABI CANADA LTD | MIDAZOLAM INJECTION | Human | Oui | Targeted (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Marketed | 02244622 | FRESENIUS KABI CANADA LTD | MILRINONE LACTATE INJECTION, USP | Human | Oui | Prescription | 1 | MILRINONE (MILRINONE LACTATE) | 1 MG / ML |
| Marketed | 02286300 | FRESENIUS KABI CANADA LTD | MITOXANTRONE INJECTION | Human | Oui | Prescription | 1 | MITOXANTRONE (MITOXANTRONE HYDROCHLORIDE) | 2 MG / ML |
| Approved | 02488620 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / 1 ML |
| Approved | 02488639 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 4 MG / 1 ML |
| Approved | 02488647 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 10 MG / 1 ML |
| Marketed | 02433087 | FRESENIUS KABI CANADA LTD | MOXIFLOXACIN INJECTION | Human | Oui | Prescription | 1 | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) | 400 MG / 250 ML |
| Cancelled Pre Market | 02243103 | FRESENIUS KABI CANADA LTD | NEOSTIGMINE METHYLSULFATE INJECTION | Human | Non | Prescription | 1 | NEOSTIGMINE METHYLSULFATE | 1 MG / ML |
| Cancelled Pre Market | 02243104 | FRESENIUS KABI CANADA LTD | NEOSTIGMINE METHYLSULFATE INJECTION | Human | Non | Prescription | 1 | NEOSTIGMINE METHYLSULFATE | 0.5 MG / ML |
| Marketed | 02554283 | FRESENIUS KABI CANADA LTD | OTULFI | Human | Oui | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02554283 | FRESENIUS KABI CANADA LTD | OTULFI | Human | Oui | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02554291 | FRESENIUS KABI CANADA LTD | OTULFI | Human | Oui | Schedule D | 1 | USTEKINUMAB | 90 MG / ML |
| Marketed | 02554291 | FRESENIUS KABI CANADA LTD | OTULFI | Human | Oui | Prescription | 1 | USTEKINUMAB | 90 MG / ML |
| Marketed | 02554305 | FRESENIUS KABI CANADA LTD | OTULFI I.V. | Human | Oui | Schedule D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02554305 | FRESENIUS KABI CANADA LTD | OTULFI I.V. | Human | Oui | Prescription | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02457423 | FRESENIUS KABI CANADA LTD | OXALIPLATIN INJECTION, USP | Human | Oui | Prescription | 1 | OXALIPLATIN | 5 MG / ML |
| Marketed | 02139561 | FRESENIUS KABI CANADA LTD | OXYTOCIN INJECTION, USP | Human | Oui | Prescription | 1 | OXYTOCIN | 10 UNIT / ML |
| Marketed | 02246597 | FRESENIUS KABI CANADA LTD | PAMIDRONATE DISODIUM FOR INJECTION | Human | Oui | Prescription | 1 | PAMIDRONATE DISODIUM | 3 MG / ML |
| Marketed | 02246598 | FRESENIUS KABI CANADA LTD | PAMIDRONATE DISODIUM FOR INJECTION | Human | Oui | Prescription | 1 | PAMIDRONATE DISODIUM | 6 MG / ML |
| Marketed | 02246599 | FRESENIUS KABI CANADA LTD | PAMIDRONATE DISODIUM FOR INJECTION | Human | Oui | Prescription | 1 | PAMIDRONATE DISODIUM | 9 MG / ML |
| Marketed | 02352214 | FRESENIUS KABI CANADA LTD | PANTOPRAZOLE FOR INJECTION | Human | Oui | Prescription | 1 | PANTOPRAZOLE (PANTOPRAZOLE SODIUM) | 40 MG / VIAL |
| Marketed | 02220261 | FRESENIUS KABI CANADA LTD | PENICILLIN G SODIUM FOR INJECTION, USP | Human | Oui | Prescription | 1 | PENICILLIN G (PENICILLIN G SODIUM) | 1000000 UNIT / VIAL |
| Marketed | 02220288 | FRESENIUS KABI CANADA LTD | PENICILLIN G SODIUM FOR INJECTION, USP | Human | Oui | Prescription | 1 | PENICILLIN G (PENICILLIN G SODIUM) | 5000000 UNIT / VIAL |
| Marketed | 02220296 | FRESENIUS KABI CANADA LTD | PENICILLIN G SODIUM FOR INJECTION, USP | Human | Oui | Prescription | 1 | PENICILLIN G (PENICILLIN G SODIUM) | 10000000 UNIT / VIAL |
| Cancelled Post Market | 02248939 | FRESENIUS KABI CANADA LTD | PIPERACILLIN FOR INJECTION | Human | Oui | Prescription | 1 | PIPERACILLIN (PIPERACILLIN SODIUM) | 2 G / VIAL |
| Cancelled Post Market | 02248940 | FRESENIUS KABI CANADA LTD | PIPERACILLIN FOR INJECTION | Human | Oui | Prescription | 1 | PIPERACILLIN (PIPERACILLIN SODIUM) | 3 G / VIAL |
| Cancelled Post Market | 02248941 | FRESENIUS KABI CANADA LTD | PIPERACILLIN FOR INJECTION | Human | Oui | Prescription | 1 | PIPERACILLIN (PIPERACILLIN SODIUM) | 4 G / VIAL |
| Approved | 02490846 | FRESENIUS KABI CANADA LTD | PLERIXAFOR INJECTION | Human | Oui | Prescription | 1 | PLERIXAFOR | 20 MG / ML |
| Dormant | 02139553 | FRESENIUS KABI CANADA LTD | POTASSIUM ACETATE INJECTION | Human | Non | Ethical | 1 | POTASSIUM ACETATE | 392 MG / ML |
| Marketed | 02139545 | FRESENIUS KABI CANADA LTD | POTASSIUM PHOSPHATES INJECTION, USP | Human | Oui | Ethical | 2 | POTASSIUM PHOSPHATE MONOBASIC | 224 MG / ML |
| Marketed | 02437643 | FRESENIUS KABI CANADA LTD | PROPOFOL INJECTION | Human | Oui | Prescription | 1 | PROPOFOL | 10 MG / ML |
| Cancelled Pre Market | 02465825 | FRESENIUS KABI CANADA LTD | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Human | Oui | Prescription | 2 | PIPERACILLIN (PIPERACILLIN SODIUM) | 12 G / VIAL |
| Marketed | 02465833 | FRESENIUS KABI CANADA LTD | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Human | Oui | Prescription | 2 | PIPERACILLIN (PIPERACILLIN SODIUM) | 36 G / VIAL |
| Marketed | 02439379 | FRESENIUS KABI CANADA LTD | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | Human | Oui | Ethical | 1 | ROPIVACAINE HYDROCHLORIDE | 2 MG / ML |
| Marketed | 02439387 | FRESENIUS KABI CANADA LTD | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | Human | Oui | Ethical | 1 | ROPIVACAINE HYDROCHLORIDE | 5 MG / ML |
| Cancelled Pre Market | 02439395 | FRESENIUS KABI CANADA LTD | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | Human | Oui | Ethical | 1 | ROPIVACAINE HYDROCHLORIDE | 7.5 MG / ML |
| Marketed | 02439409 | FRESENIUS KABI CANADA LTD | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | Human | Oui | Ethical | 1 | ROPIVACAINE HYDROCHLORIDE | 10 MG / ML |
| Marketed | 02440695 | FRESENIUS KABI CANADA LTD | SMOFKABIVEN | Human | Oui | Ethical | 27 | HISTIDINE | 0.15 G / 100 ML |
| Marketed | 02440687 | FRESENIUS KABI CANADA LTD | SMOFKABIVEN ELECTROLYTE FREE | Human | Oui | Ethical | 21 | SOYBEAN OIL | 1.14 G / 100 ML |
| Marketed | 02501813 | FRESENIUS KABI CANADA LTD | SMOFKABIVEN EXTRA NITROGEN | Human | Oui | Ethical | 27 | DEXTROSE | 8.5 G / 100 ML |
| Marketed | 02501775 | FRESENIUS KABI CANADA LTD | SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE | Human | Oui | Ethical | 21 | DEXTROSE | 8.5 G / 100 ML |
| Marketed | 02456206 | FRESENIUS KABI CANADA LTD | SMOFKABIVEN PERIPHERAL | Human | Oui | Ethical | 27 | SOYBEAN OIL | 850 MG / 100 ML |
| Marketed | 02396963 | FRESENIUS KABI CANADA LTD | SMOFLIPID 20% | Human | Oui | Ethical | 4 | SOYBEAN OIL | 6 % / W/V |
| Marketed | 02139529 | FRESENIUS KABI CANADA LTD | SODIUM ACETATE INJECTION, USP | Human | Oui | Ethical | 1 | SODIUM ACETATE | 328 MG / ML |
| Marketed | 02486628 | FRESENIUS KABI CANADA LTD | SODIUM BICARBONATE INJECTION, USP | Human | Oui | Ethical | 1 | SODIUM BICARBONATE | 42 MG / ML |
| Marketed | 02486636 | FRESENIUS KABI CANADA LTD | SODIUM BICARBONATE INJECTION, USP | Human | Oui | Ethical | 1 | SODIUM BICARBONATE | 84 MG / ML |
| Approved | 02547880 | FRESENIUS KABI CANADA LTD | SUGAMMADEX INJECTION | Human | Oui | Prescription | 1 | SUGAMMADEX (SUGAMMADEX SODIUM) | 100 MG / ML |
| Marketed | 02482681 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / 1 ML |
| Approved | 02482703 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 4 MG / 1 ML |
| Approved | 02482711 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 5 MG / 1 ML |
| Cancelled Pre Market | 02482738 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 8 MG / 1 ML |
| Marketed | 02482746 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Oui | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 10 MG / 1 ML |
| Marketed | 02139537 | FRESENIUS KABI CANADA LTD | PROTAMINE SULFATE INJECTION, USP | Human | Non | Ethical | 1 | PROTAMINE SULFATE | 10 MG / ML |
| Dormant | 02230639 | FRESENIUS KABI CANADA LTD | TOBRAMYCIN INJECTION | Human | Oui | Prescription | 1 | TOBRAMYCIN (TOBRAMYCIN SULFATE) | 10 MG / ML |
| Marketed | 02230640 | FRESENIUS KABI CANADA LTD | TOBRAMYCIN INJECTION | Human | Oui | Prescription | 1 | TOBRAMYCIN (TOBRAMYCIN SULFATE) | 40 MG / ML |
| Marketed | 00533688 | FRESENIUS KABI CANADA LTD | TOBRAMYCIN FOR INJECTION | Human | Oui | Prescription | 1 | TOBRAMYCIN (TOBRAMYCIN SULFATE) | 1.2 G / VIAL |
| Cancelled Post Market | 02346656 | FRESENIUS KABI CANADA LTD | TOPOTECAN FOR INJECTION | Human | Oui | Prescription | 1 | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) | 4 MG / VIAL |
| Marketed | 02552450 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Prescription | 1 | TOCILIZUMAB | 80 MG / 4 ML |
| Marketed | 02552450 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Schedule D | 1 | TOCILIZUMAB | 80 MG / 4 ML |
| Marketed | 02552469 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Prescription | 1 | TOCILIZUMAB | 200 MG / 10 ML |
| Marketed | 02552469 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Schedule D | 1 | TOCILIZUMAB | 200 MG / 10 ML |
| Marketed | 02552477 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Prescription | 1 | TOCILIZUMAB | 400 MG / 20 ML |
| Marketed | 02552477 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Schedule D | 1 | TOCILIZUMAB | 400 MG / 20 ML |
| Marketed | 02552485 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Prescription | 1 | TOCILIZUMAB | 162 MG / 0.9 ML |
| Marketed | 02552485 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Schedule D | 1 | TOCILIZUMAB | 162 MG / 0.9 ML |
| Marketed | 02552493 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Prescription | 1 | TOCILIZUMAB | 162 MG / 0.9 ML |
| Marketed | 02552493 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Oui | Schedule D | 1 | TOCILIZUMAB | 162 MG / 0.9 ML |
| Marketed | 02139243 | FRESENIUS KABI CANADA LTD | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Human | Oui | Prescription | 1 | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 5 G / VIAL |
| Marketed | 02139375 | FRESENIUS KABI CANADA LTD | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Human | Oui | Prescription | 1 | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 500 MG / VIAL |
| Marketed | 02139383 | FRESENIUS KABI CANADA LTD | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Human | Oui | Prescription | 1 | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 1 G / VIAL |
| Marketed | 02241807 | FRESENIUS KABI CANADA LTD | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Human | Oui | Prescription | 1 | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 10 G / VIAL |
| Marketed | 02139502 | FRESENIUS KABI CANADA LTD | VASOPRESSIN INJECTION, USP | Human | Oui | Prescription | 1 | VASOPRESSIN | 20 UNIT / ML |
| Cancelled Post Market | 02265990 | FRESENIUS KABI CANADA LTD | VINORELBINE INJECTION | Human | Oui | Prescription | 1 | VINORELBINE (VINORELBINE TARTRATE) | 10 MG / ML |
| Marketed | 02511347 | FRESENIUS KABI CANADA LTD | VINORELBINE INJECTION, USP | Human | Oui | Prescription | 1 | VINORELBINE (VINORELBINE TARTRATE) | 10 MG / ML |
| Marketed | 02357291 | FRESENIUS KABI CANADA LTD | VOLULYTE | Human | Oui | Prescription | 1 | HYDROXYETHYL STARCH 130/0.4 | 6 % |
| Marketed | 02278057 | FRESENIUS KABI CANADA LTD | VOLUVEN | Human | Oui | Prescription | 1 | HYDROXYETHYL STARCH 130/0.4 | 6 % |
| Marketed | 02493829 | FRESENIUS KABI CANADA LTD | VORICONAZOLE FOR INJECTION | Human | Oui | Prescription | 1 | VORICONAZOLE | 200 MG / VIAL |
| Marketed | 02532972 | FRESENIUS KABI CANADA LTD | ZINC SULFATE INJECTION, USP | Human | Oui | Ethical | 1 | ZINC (ZINC SULFATE) | 1 MG / ML |
| Marketed | 02532980 | FRESENIUS KABI CANADA LTD | ZINC SULFATE INJECTION, USP | Human | Oui | Ethical | 1 | ZINC (ZINC SULFATE) | 5 MG / ML |
Information sur l'application
Information complémentaire
Contactez-nous
Version 4.0.3